Secukinumab 150mg/1ml solution for injection pre-filled disposable devices
NHS hospitals in England used £58,772,009 of indicative cost of Secukinumab 150mg/1ml solution for injection pre-filled disposable devices in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 0.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Secukinumab 150mg/1ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Secukinumab 150mg/1ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £2,115,802 |
| South Tyneside And Sunderland Nhs Ft | £1,820,857 |
| Hull And East Yorkshire Hpls Nhs Trust | £1,728,230 |
| Barts Health Nhs Trust | £1,461,927 |
| Portsmouth Hospitals Nhs Trust | £1,305,313 |
| Leeds Teaching Hpls Nhs Trust | £1,275,453 |
| Royal Free London Nhs Foundation Trust | £1,259,000 |
| Oxford University Hospitals Nhs Ft | £1,207,811 |
| Dudley Group Nhs Foundation Trust | £1,139,559 |
| Derby Teaching Hospitals Nhs Found Trust | £1,006,103 |
The primary-care picture
Secukinumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Secukinumab medicine page.